NewsBenzinga코렛 크레스의 첫 엔비디아 실적 발표, 젠슨 황 없이 진행···투자자들이 알아야 할 5가지 코렛 크레스의 첫 엔비디아 실적 발표, 젠슨 황 없이 진행···투자자들이 알아야 할 5가지 Benzinga 2026.11.13 14:42 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report